100391-96-6

Basic information

• Product Name: 1-(phenyl-methanesulfonyl)-L-proline
• Synonyms: 1-(phenyl-methanesulfonyl)-L-proline
• CAS NO: 100391-96-6
• Molecular Weight: 269.321
• Mol File: 100391-96-6.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 1-(phenyl-methanesulfonyl)-L-proline(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(phenyl-methanesulfonyl)-L-proline(100391-96-6)
• EPA Substance Registry System: 1-(phenyl-methanesulfonyl)-L-proline(100391-96-6)

Safety Data

• Hazardous Substances Data: 100391-96-6(Hazardous Substances Data)

Usage

Appearance

White to off-white crystalline powder

Solubility

Insoluble in water, soluble in organic solvents

Usage

Reagent in organic synthesis and pharmaceutical research

Function

Acts as a chiral auxiliary in asymmetric synthesis

Application

Preparation of various pharmaceutical intermediates

Potential

Studied for use as a therapeutic agent in the treatment of various medical conditions

Upstream product

• 147-85-3 L-proline 
• 1939-99-7 benzenesulfonyl chloride 
• 2133-40-6 L-proline methyl ester monohydrochloride 
• 420106-65-6 C₁₃H₁₇NO₄S 
• 2577-48-2 methyl (2S)-pyrrolidine carboxylate 

Downstream Products

• 1312610-76-6 C₄₄H₄₂N₂O₁₀S₂ 

Relevant articles and documents

NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION

The embodiments provide compounds of the general Formulae I, II, III, IV, or V as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.

Method for treating nerve injury caused as a result of surgery

The present invention relates generally to methods for treating or preventing nerve injury in a warm-blooded animal caused as a consequence of surgery by administering neurotrophic compounds described below. The invention relates more specifically to methods for treating or preventing nerve injury caused as a consequence of prostate surgery as well as erectile dysfunction.

N-linked sulfonamides of N-heterocyclic carboxylic acids or isosteres for vision and memory disorders

This invention relates to novel compositions and uses of a N-linked sulfonamide of an N-heterocylic carboxylic acid or isostere thereof for treating a vision disorder or improving vision or treating memory impairment or enhancing memory performance in an animal.